Targeting lipid metabolism: novel insights and therapeutic advances in pancreatic cancer treatment
Lipids in Health and Disease · 13.01.2025 · 24 (1)
DOI: 10.1186/s12944-024-02426-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Lipids in Health and Disease, online erschienen am 13.01.2025. Verfasst von Yanyan Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Qinba State Key Laboratory of Biological Resources and Ecological Environment, Shaanxi Province Key Laboratory of Bio-Resources, College of Bioscienc…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Lipid Metabolism, Antineoplastic Agents. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Lipid metabolism in cancer is characterized by dysregulated lipid regulation and utilization, critical for promoting tumor growth, survival, and resistance to therapy. Pancreatic cancer (PC) is a highly aggressive malignancy of the gastrointestinal tract that has a dismal 5-year survival rate of less than 10%. Given the essential function of the pancreas in digestion, cancer progression severely disrupts its function. Standard treatments for PC such as surgical resection, chemotherapy, and radiotherapy. However, these therapies often face significant challenges, including biochemical recurrence and drug resistance.Given these limitations, new therapeutic approaches are being developed to target tumor metabolism. Dysregulation of cholesterol biosynthesis and alterations in fatty acids (FAs), such as palmitate, stearate, omega-3, and omega-6, have been observed in pancreatic cancer. These lipids serve as energy sources, signaling molecules, and essential components of cell membranes. Their accumulation fosters an immunosuppressive tumor microenvironment that supports cancer cell proliferation and metastasis.Moreover, lipid metabolism dysregulation within immune cells, particularly T cells, impairs immune surveillance and weakens the body's defenses against cancer. Abnormal lipid metabolism also contributes to drug resistance in PC. Despite these challenges, targeting lipid metabolism may offer a promising therapeutic strategy. By enhancing lipid peroxidation, the induction of ferroptosis-a form of regulated cell death-could impair the survival of PC cells and hinder disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Qinba State Key Laboratory of Biological Resources and Ecological Environment, Shaanxi Province Key Laboratory of Bio-Resources, College of Bioscience and Bioengineering, Bashan Mountains Bioresources Comprehensive Deve…
- Department of Epidemiology and Health Statistics, School of Public Health, Dalian Medical University, Dalian, China.
- Interventional Therapy Department, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116023, P.R. China. liruojie0120@163.com.
- Emergency surgery Dapartment (Trauma center), The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang, 471003, Henan, China. yangyanhui63@163.com.
Zitieren
APA
Zhang, Y., Yang, Z., Liu, Y., Pei, J., Li, R., & Yang, Y. (2025). Targeting lipid metabolism: novel insights and therapeutic advances in pancreatic cancer treatment. Lipids in Health and Disease, 24(1). https://doi.org/10.1186/s12944-024-02426-0
Vancouver
Zhang Y, Yang Z, Liu Y, Pei J, Li R, Yang Y. Targeting lipid metabolism: novel insights and therapeutic advances in pancreatic cancer treatment. Lipids in Health and Disease. 2025;24(1). doi:10.1186/s12944-024-02426-0
BibTeX
@article{Zhang2025,
author = {Zhang, Yanyan and Yang, Zhichao and Liu, Yuchen and Pei, Jinjin and Li, Ruojie and Yang, Yanhui},
title = {Targeting lipid metabolism: novel insights and therapeutic advances in pancreatic cancer treatment},
journal = {Lipids in Health and Disease},
year = {2025},
volume = {24},
number = {1},
doi = {10.1186/s12944-024-02426-0}
}
EUVIMED